VELA-1 and VELA-2 are two identical trials to evaluate the efficacy and safety of sonelokimab in adult participants with moderate to severe hidradenitis suppurativa (HS) and the first Phase 3 ...
VELA-1 and VELA-2 are two identical trials to evaluate the efficacy and safety of sonelokimab in adult participants with moderate to severe hidradenitis suppurativa (HS) and the first Phase 3 program ...
Objectives Structural MRI of the brain is routinely performed on patients referred to memory clinics; however, resulting ...
Background Hospitalisation with acute heart failure (AHF) carries a high risk of death, and those surviving to discharge ...
Dr. Jani highlighted the EMPIRE-1 trial, which evaluated the role of 18F-fluciclovine PET in guiding post-prostatectomy radiotherapy. The study demonstrated an improvement in 3-year freedom from ...
Aim To identify subgroups of early rheumatoid arthritis (RA) based on comorbidities and RA manifestations and to investigate ...
CAMX 2025 showcased the power of collaboration and purposeful innovation, a clear reminder that the composites industry is all about human potential.
Q4 2025 Earnings Call September 29, 2025 5:00 PM EDTCompany ParticipantsAngela Korch - Executive VP & CFORobert Katz - ...
In this important work, the authors present a new transformer-based neural network designed to isolate and quantify higher-order epistasis in protein sequences. They provide solid evidence that higher ...
A vegan, a ketogenic dieter and a Mediterranean diet adherent walk into a bar… My topic for the blog post this week was born ...
Background: Determining optimal timing for intensifying the frequency of physician encounters for type 2 diabetes mellitus (T2DM) requires trade-offs between timely care and clinician burden. We aimed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback